Trial intelligence / Profile preview

Givinostat Extension in Polyarticular JIA

NCT01557452Phase 2Terminated

Sponsor
Italfarmaco
Start
Dec 2011
Primary completion
Jan 2014
Modality
Covalent Small Molecules, Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 2 trial of givinostat in juvenile idiopathic arthritis (JIA), sponsored by Italfarmaco. Started Dec 2011; status: terminated.

02

Drugs

givinostat
03

Conditions

juvenile idiopathic arthritis (JIA)

Beyond the preview

Go deeper on NCT01557452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01557452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call